Zimmer Biomet Holdings (ZBH) Shares are Down -0.79%

Zimmer Biomet Holdings (ZBH) : During the past 4 weeks, traders have been relatively bearish on Zimmer Biomet Holdings (ZBH), hence the stock is down -0.71% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -1.32% relative to the S&P 500. The 4-week change in the price of the stock is -2.72% and the stock has fallen -0.79% in the past 1 week.

The stock has recorded a 20-day Moving Average of 2.92% and the 50-Day Moving Average is 2.62%.The 200 Day SMA reached 10.71% Zimmer Biomet Holdings, Inc. is up 6.93% in the last 3-month period. Year-to-Date the stock performance stands at 21.69%.


Zimmer Biomet Holdings (ZBH) : The consensus price target for Zimmer Biomet Holdings (ZBH) is $142.47 for the short term with a standard deviation of $10.06. The most optimist securities analyst among the 15 who monitor the stock believes that the stock can reach $155, however, the pessimist price target for the company is $120.

For the current week, the company shares have a recommendation consensus of Buy. Zimmer Biomet Holdings (NYSE:ZBH): stock was range-bound between the intraday low of $123.53 and the intraday high of $124.98 after having opened at $124.6 on Fridays session. The stock finally closed in the red at $124.6, a loss of -0.47%. The stock remained in the red for the whole trading day. The total traded volume was 1,590,598 shares. The stock failed to cross $124.98 in Fridays trading. The stocks closing price on Thursday was $124.89.

Zimmer Biomet Holdings, Inc., formerly Zimmer Holdings, Inc. is a musculoskeletal healthcare company. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company manages its operations through three geographic segments: the Americas, comprising principally of the United States and includes other North, Central and South American markets; Europe, comprising principally of Europe and includes the Middle East and African markets; and Asia Pacific, comprising primarily of Japan and includes other Asian and Pacific markets. The Company markets and sells products through three channels: direct to healthcare institutions, such as hospitals or direct channel accounts; through stocking distributors and healthcare dealers, and directly to dental practices and dental laboratories.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.